Parataxis Holdings plans to launch a Bitcoin finance platform in South Korea through an acquisition transaction worth approximately $18.29 million

According to a report by US News Agency, Parataxis Holdings, a Bitcoin focused investment startup, announced that it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion Korean won (approximately $18.29 million) to give Parataxis Holdings a controlling stake in the company, in order to acquire South Korean Bridge Biotherapeutics and launch an institution backed Bitcoin financial platform in the South Korean public market. This transaction will create a native Bitcoin based fund management platform on the South Korean public market, supported by institutional investors with extensive experience in digital asset investment. Previously, it was reported that Parataxi Holdings plans to go public through SPAC trading, but the transaction still needs to complete due diligence, sign the final agreement, and obtain regulatory approval through routine procedures.